Contact
Subscribe

Category

Posters

[article_filters]
Website_ASH

ASH 2017: ASH 2017: Prevention of dysbiosis complications with autologous fecal microbiota transplantation (auto-FMT) in AML patients undergoing intensive treatment (ODYSSEE study): First results of a prospective multicenter trial

MaaT Pharma
December 10, 2017

We are a clinical-stage microbiome therapeutics company aiming to improve survival in cancer.

COMPANY

Ressources

Contact

We are a clinical-stage microbiome therapeutics company aiming to improve survival in cancer.

COMPANY

Ressources

Contact

MaaT Pharma in the News